# A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping

> **NCT07164703** · — · NOT_YET_RECRUITING · sponsor: **Mao-Lin Yan** · enrollment: 55 (estimated)

## Conditions studied

- Advanced Cholangiocarcinoma (Part 1)

## Interventions

- **DRUG:** Targeted drugs or immunotherapies for cholangiocarcinoma based on targetable gene mutations.

## Key facts

- **NCT ID:** NCT07164703
- **Lead sponsor:** Mao-Lin Yan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-01
- **Primary completion:** 2029-10-01
- **Final completion:** 2029-10-31
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07164703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07164703, "A Real-World Study of Precision Treatment for Advanced Cholangiocarcinoma Based on Molecular Subtyping". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07164703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*